Page content
Contact details
Miguel-Angel Macia
Main
Bifap contact
Alternate
Publications
Data source publications
- Updated list of Scientific Publications in peer reviewed journals describing the use of BIFAP for pharmacoepidemiology research linked to their respective DOIs.
- Maciá-Martínez M-A, Gil M, Huerta C, et al. Base de Datos para la Investigación Farmacoepidemiológica en Atención Primaria (BIFAP): A data resource for pharmacoepidemiology in Spain. Pharmacoepidemiol Drug Saf. 2020;1–10. https://doi.org/10.1002/pds.5006
Studies
List of studies that have been conducted using the data source
- ADVANCE POC I Risk pillar - Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: Incidence rates of safety outcomes of whole-cell pertussis and acellular pertussis vaccines in pre-school children
- ADVANCE POC Study Protocol - Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case. Coverage rates of acellular and whole-cell pertussis-containing vaccines in preschool children (ADVANCE Coverage POC)
- Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: Incidence rates of pertussis and pertussis related outcomes of whole-cell pertussis and acellular pertussis vaccines in pre-school children (benefit study on pertussis vaccination)
- Exposure and coverage to routine schedule vaccines in different EU countries (ADVANCE-POC2)
- The risk of acute liver injury associated with the use of antibiotics. A methodological comparison across epidemiological data sources
- NESTED CASE-CONTROL STUDY TO ASSESS THE ASSOCIATION BETWEEN THE USE OF METHYLPHENIDATE AND THE RISK OF VALVULAR HEART DISEASE AND PULMONARY HYPERTENSION
- USE OF DRUGS ACTING ON RENIN-ANGIOTENSIN SYSTEM (RAS) AND RISK OF COVID-19: A CASE-POPULATION STUDY (SRAA-COVID19)
- Real-world effectiveness of different COVID-19 vaccines in Spain: a cohort study based on public electronic health records (BIFAP) (effectiveness of COVID-19 vaccines in Spain)
- Characterising the risk of major bleeding in patients with Non-Valvular Atrial Fibrillation: non-interventional study of patients taking Direct Oral Anticoagulants in the EU
- Metamizole and risk of agranulocytosis
- Risk of thromboembolic events and thrombocytopenia after vaccination against COVID-19 (Thrombosis risk COVID-19 vaccination)
- Establish an EU catalogue of sources of real-world data, characterised by a common set of metadata and data quality measurements
- Strengthening Use of Real-World Data in Medicines Development: Metadata for Data Discoverability and Study Replicability (MINERVA)
- Impact of EU label changes and revised pregnancy prevention programme for oral retinoid containing medicinal products: utilization and prescribing trends
- Impact of EU label changes and revised pregnancy prevention programme for medicinal products containing valproate: utilisation and prescribing trends
- Effectiveness of heterologous and booster Covid-19 vaccination in 5 European countries, using a cohort approach in children and adults with a full primary Covid-19 vaccination regimen (Covid Vaccines Effectiveness (CoVE))
- Cohort monitoring of Adverse Events of Special Interest and COVID-19 diagnoses prior to and after COVID-19 vaccination (ECVM)
- Rapid Safety Assessment of SARS-CoV-2 vaccines in EU Member States using electronic health care datasources (CVM Covid19-Vaccine-Monitor-EHR)
- Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines (ACCESS-BGR)
- Effectiveness of antiresorptives in preventing hip fractures in older women (≥ 75 years) with osteoporosis: nested case-control study cohort (BiHip)
- DARWIN EU® - Chondrosarcoma: patient demographics, treatments, and survival in the period 2010-2023
- DARWIN EU® - Characterising interstitial lung disease in Europe
- SAFETY-VAC: a framework for the post-authorisation safety monitoring and evaluation of vaccines in the European Union (SAFETY-VAC)
- The utilisation of antiepileptics in men and women of childbearing age, and pregnant women in Europe (ADEPT)
- DARWIN EU® – Trends in utilisation of Attention-Deficit Hyperactivity Disorder (ADHD) Medications
- Background incidence rates of disease flares of Graves' disease, Hashimoto's thyroiditis, polyarteritis nodosa, autoimmune hepatitis, rheumatoid arthritis, psoriatic arthritis, multiple sclerosis, erythema nodosum, systemic lupus erythematosus, and ulcerative colitis using electronic healthcare data sources in 7 European countries. A SAFETY-VAC study. (SAFETY-VAC)
- Detection of therapeutic cascades associated with gabapentinoids and benzodiazepines in adults over 65 years old in Spain using BIFAP through prescription sequence symmetry analysis (GABALOOP)
- ADEPT: feasibility of estimating the risk of adverse pregnancy, neonatal and child outcomes following either in utero ASM exposure through the mother, or peri-conceptional ASM exposure through the father.
- INCIDENCIA Y PREVALENCIA DE HIPOTIROIDISMO EN ESPAÑA, COMORBILIDAD, TRATAMIENTO Y ASOCIACION CON EFECTOS ADVERSOS DE SALUD (GRACHIPES)